the aim of this study was to determine whether positron emission tomography ( pet ) with fluorine-18 ( 18f ) -2-deoxyglucose ( fdg ) can be used as a prognostic test in patients with high-grade cerebral gliomas , regardless of the treatment given .
C0011501
2-deoxyglucose
C0046056
fdg